| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $17.5M | +9.7% |
| Cost of Revenue | $2.9M | +1.0% |
| R&D Expense | $43.2M | +122.5% |
| SG&A Expense | $44.7M | +38.0% |
| Operating Income | -$73.4M | -89.3% |
| Interest Expense | $6.3M | +168.3% |
| Income Tax | $0 | — |
| Net Income | -$78.5M | -91.4% |
| EPS (Basic) | -$1.21 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $83.7M | -10.3% |
| Accounts Receivable | $4.1M | -19.1% |
| Current Assets | $89.9M | -9.9% |
| Total Assets | $118.3M | -8.4% |
| Current Liabilities | $18.6M | +110.8% |
| Long-term Debt | $19.9M | +0.0% |
| Total Liabilities | $71.0M | +83.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$41.6M | -45.4% |
| Capital Expenditures | $1.3M | +117.9% |
| Investing Cash Flow | -$11.3M | -1823.0% |
| Financing Cash Flow | $43.2M | -33.4% |
| Free Cash Flow | -$42.9M | -46.9% |
| -80.6% |
| EPS (Diluted) | -$1.21 | -80.6% |
| Stockholders' Equity |
| $47.3M |
| -47.7% |